Abstract
Type 1 diabetics receiving once (Group 1, n = 72) and twice (Group 2, n = 48) daily subcutaneous injections of conventional beef insulin were compared, on a cross-sectional basis, in respect of insulin antibody binding by serum and total glycosylated haemoglobin (HbA1). Patients in Group 1 had higher insulin antibody binding (25.2 ± 15.8% vs 17.0 ± 13.9%; p < 0.01) and higher HbA1 levels (12.5 ± 2.0% vs 11.0 ± 1.8%; p < 0.001) than patients in Group 2.
An inverse correlation (τ = –0.28, p < 0.01) was observed between HbA1 and insulin antibody binding in C-peptide non-secretors of Group 1 but not in Group 1 C-peptide secretors, nor in C-peptide secretors and/or non-secretors of Group 2. It is suggested that in Type 1 diabetics who receive a single daily insulin injection and who have no endogenous insulin secretion, insulin antibodies may aid glycaemic control by prolonging insulin action.
Get full access to this article
View all access options for this article.